XML 35 R25.htm IDEA: XBRL DOCUMENT v3.22.2.2
Acquisition of Atrin (Details) - Atrin Pharmaceuticals, Inc
$ in Millions
3 Months Ended
May 16, 2022
USD ($)
shares
Jun. 30, 2022
shares
Acquisition of Atrin    
Preferred stock conversion ratio 10  
Cost to acquire Atrin assets | $ $ 76.2  
Direct costs of acquisition of Atrin assets | $ $ 3.5  
Term of contingent value right 2 years  
Common Stock    
Acquisition of Atrin    
Issuance of common stock upon acquisition of Atrin (in shares) | shares 1,117,394  
Series A Preferred Stock    
Acquisition of Atrin    
Issuance of preferred stock upon acquisition of Atrin (in shares) | shares 2,949,630 2,949,630
Preferred stock conversion ratio 10